Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Lung Cell Mol Physiol ; 309(8): L879-87, 2015 Oct 15.
Article in English | MEDLINE | ID: mdl-26254422

ABSTRACT

Pulmonary fibrosis is a common and dose-limiting side-effect of ionizing radiation used to treat cancers of the thoracic region. Few effective therapies are available for this disease. Pulmonary fibrosis is characterized by an accumulation of myofibroblasts and excess deposition of extracellular matrix proteins. Although prior studies have reported that ionizing radiation induces fibroblast to myofibroblast differentiation and collagen production, the mechanism remains unclear. Transforming growth factor-ß (TGF-ß) is a key profibrotic cytokine that drives myofibroblast differentiation and extracellular matrix production. However, its activation and precise role in radiation-induced fibrosis are poorly understood. Recently, we reported that lactate activates latent TGF-ß through a pH-dependent mechanism. Here, we wanted to test the hypothesis that ionizing radiation leads to excessive lactate production via expression of the enzyme lactate dehydrogenase-A (LDHA) to promote myofibroblast differentiation. We found that LDHA expression is increased in human and animal lung tissue exposed to ionizing radiation. We demonstrate that ionizing radiation induces LDHA, lactate production, and extracellular acidification in primary human lung fibroblasts in a dose-dependent manner. We also demonstrate that genetic and pharmacologic inhibition of LDHA protects against radiation-induced myofibroblast differentiation. Furthermore, LDHA inhibition protects from radiation-induced activation of TGF-ß. We propose a profibrotic feed forward loop, in which radiation induces LDHA expression and lactate production, which can lead to further activation of TGF-ß to drive the fibrotic process. These studies support the concept of LDHA as an important therapeutic target in radiation-induced pulmonary fibrosis.


Subject(s)
L-Lactate Dehydrogenase/metabolism , Myofibroblasts/radiation effects , Animals , Cell Differentiation/radiation effects , Cells, Cultured , Enzyme Inhibitors/pharmacology , Gossypol/pharmacology , Humans , Isoenzymes/antagonists & inhibitors , Isoenzymes/metabolism , L-Lactate Dehydrogenase/antagonists & inhibitors , Lactate Dehydrogenase 5 , Lactic Acid/biosynthesis , Lung/enzymology , Lung/radiation effects , Mice , Mice, Inbred C57BL , Models, Biological , Myofibroblasts/cytology , Myofibroblasts/enzymology , Pulmonary Fibrosis/enzymology , Pulmonary Fibrosis/etiology , Radiation Injuries/enzymology , Radiation Injuries/etiology , Transforming Growth Factor beta/metabolism
2.
PPAR Res ; 2010: 814609, 2010.
Article in English | MEDLINE | ID: mdl-20204067

ABSTRACT

The use of targeted cancer therapies in combination with conventional chemotherapeutic agents and/or radiation treatment has increased overall survival of cancer patients. However, longer survival is accompanied by increased incidence of comorbidities due, in part, to drug side effects and toxicities. It is well accepted that inflammation and tumorigenesis are linked. Because peroxisome proliferator-activated receptor (PPAR)-gamma agonists are potent mediators of anti-inflammatory responses, it was a logical extension to examine the role of PPARgamma agonists in the treatment and prevention of cancer. This paper has two objectives: first to highlight the potential uses for PPARgamma agonists in anticancer therapy with special emphasis on their role when used as adjuvant or combined therapy in the treatment of hematological malignancies found in the vasculature, marrow, and eyes, and second, to review the potential role PPARgamma and/or its ligands may have in modulating cancer-associated angiogenesis and tumor-stromal microenvironment crosstalk in bone marrow.

3.
J Environ Qual ; 30(5): 1756-70, 2001.
Article in English | MEDLINE | ID: mdl-11577885

ABSTRACT

Three years of field data, classical linear reservoir theory, and a new dissolution model confirm the hypothesis that residual chloride from highway deicing applications dissolves into precipitation throughout the year. The measured input includes 52 storm hyetographs and logs of salt and premix applications on an access road with a closed drainage system subject to runoff, interflow, and baseflow. The output data feature discharge and conductivity in an outlet weir measured continuously from February 1998 to May 2000. Individual storm hydrographs and pollutographs yield calibrated first flush dissolved chloride concentrations and residual solid chloride loads that persist at appreciable levels over the entire period of record. The storm calibrations imply a source strength w of 2.01 x 10(-6) s(-1) that accurately models chloride dissolution kinetics through three salt seasons on the access road. This w rests on physically plausible values for the depression storage depth zeta (3 mm) and porosity n (0.40) that store the residual chloride.


Subject(s)
Chlorides/analysis , Models, Theoretical , Rain , Water Movements , Water Pollutants/analysis , Calibration , Chlorides/chemistry , Kinetics , Motor Vehicles , Solubility
5.
Curr Top Microbiol Immunol ; 252: 293-300, 2000.
Article in English | MEDLINE | ID: mdl-11187084
SELECTION OF CITATIONS
SEARCH DETAIL
...